Acadian Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,371
Closed -$349K 1803
2024
Q4
$349K Buy
14,371
+13,776
+2,315% +$393K ﹤0.01% 1157
2024
Q3
$22K Buy
+595
New +$22.2K ﹤0.01% 1967
2023
Q1
Sell
-9,607
Closed -$464K 1965
2022
Q4
$464K Buy
+9,607
New +$603K ﹤0.01% 1053
2021
Q3
Sell
-394
Closed -$60K 1999
2021
Q2
$60K Buy
+394
New +$51.9K ﹤0.01% 1776
2020
Q2
Sell
-5,116
Closed -$165K 2334
2020
Q1
$165K Buy
+5,116
New +$172K ﹤0.01% 1238
2019
Q3
Sell
-1,423
Closed -$42K 1997
2019
Q2
$42K Sell
1,423
-73,794
-98% -$2.13M ﹤0.01% 1507
2019
Q1
$2.57M Sell
75,217
-60,350
-45% -$2.14M 0.01% 630
2018
Q4
$4.33M Sell
135,567
-20,264
-13% -$790K 0.02% 400
2018
Q3
$7.48M Sell
155,831
-4,476
-3% -$183K 0.03% 324
2018
Q2
$4.97M Buy
+160,307
New +$3.75M 0.02% 388

Other funds holding STAA

Acadian Asset Management's STAA Position: Q1 2025 in Review

Acadian Asset Management sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 14,371 shares — an estimated $349K sold.

Acadian Asset Management first reported a position in STAA in Q2 2018 and held it in 10 quarters. The position peaked at $7.48M in Q3 2018. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Acadian Asset Management reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Acadian Asset Management sold 14,371 STAAR Surgical shares in Q1 2025, an estimated $349K.
  • Acadian Asset Management first reported a position in STAAR Surgical in Q2 2018 and held it in 10 quarters.
  • Acadian Asset Management's STAAR Surgical position peaked at $7.48M in Q3 2018.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Acadian Asset Management's 13F filing for Q1 2025, filed 21 May 2025.